Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Assets (2018 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Other Non-Current Assets for 3 consecutive years, with $1.2 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Other Non-Current Assets changed 0.0% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2021, changed 0.0%, and an annual FY2020 reading of $1.2 million, down 46.9% over the prior year.
  • Other Non-Current Assets was $1.2 million for Q3 2021 at Black Diamond Therapeutics, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.3 million in Q4 2019 and bottomed at $55000.0 in Q2 2019.
  • Average Other Non-Current Assets over 3 years is $863800.0, with a median of $1.2 million recorded in 2020.
  • Peak annual rise in Other Non-Current Assets hit 2123.64% in 2020, while the deepest fall reached 46.9% in 2020.
  • Year by year, Other Non-Current Assets stood at $2.3 million in 2019, then crashed by 46.9% to $1.2 million in 2020, then changed by 0.0% to $1.2 million in 2021.
  • Business Quant data shows Other Non-Current Assets for BDTX at $1.2 million in Q3 2021, $1.2 million in Q2 2021, and $1.2 million in Q1 2021.